124 countries vote in favor of a draft agreement addressing health inequities, while 11 remain abstained, including Poland and Russia.
At the World Health Assembly in Geneva, a significant draft agreement aimed at addressing structural inequalities in the development of medicines,
vaccines, and health tools received broad support, with 124 nations voting in favor.
The motion, initiated by Slovakia, prompted a formal vote despite the nation's Prime Minister, Robert Fico, expressing skepticism towards
COVID-19
vaccines and calling for his country to contest the adoption of the agreement.
The vote concluded with no nation opposing the draft, although 11 nations, including Poland, Israel, Italy, Russia, Slovakia, and Iran, chose to abstain.
This mixed response highlights the complex dynamics surrounding
vaccine confidence and pandemic preparedness on a global scale.
The formal adoption of the agreement is expected to take place during a plenary session of the World Health Assembly on Tuesday.
However, implementation of the agreement will not commence until negotiations are completed regarding an annex on pathogen sharing, a process that could extend over the next two years.
Once finalized, individual countries will need to ratify the agreement before it can take effect.
This initiative comes in the context of rising concerns from the World Health Organization regarding the potential for new pandemics, emphasizing the importance of global cooperation in health responses.
Experts have noted that challenges in managing emerging diseases could pose greater threats than
COVID-19, necessitating robust frameworks for international health collaboration.